Comparative Effectiveness of Angiotensin II Receptor Blockers in Patients With Hypertension in Japan ― Systematic Review and Network Meta-Analysis ―
Open Access
- 9 October 2020
- journal article
- review article
- Published by Japanese Circulation Society in Circulation Reports
- Vol. 2 (10), 576-586
- https://doi.org/10.1253/circrep.cr-20-0076
Abstract
Background:Angiotensin II receptor blockers (ARBs) are widely used for the management of hypertension in Japan; however, comparative efficacy data within the ARB drug class remain limited. Methods and Results:This systematic literature review identified randomized controlled trials (RCT) indexed in PubMed and Ichushi in Japanese patients with hypertension receiving ARB monotherapy (azilsartan, candesartan cilexetil, irbesartan, losartan potassium, olmesartan medoxomil, telmisartan, valsartan) in at least 1 arm. Of 763 RCTs identified, 77 met the eligibility criteria; of which, 37 reported mean change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) from baseline in the office setting and were used to construct the network. A fixed-effects model (FEM) showed the effect of each drug vs. the reference, azilsartan. Using the FEM, the mean (95% credible interval) change from baseline in SBP/DBP for candesartan cilexetil, irbesartan, losartan potassium, olmesartan medoxomil, telmisartan, and valsartan was 3.8 (2.9–4.8)/2.6 (2.0–3.1), 4.8 (2.0–7.5)/3.7 (1.8–5.6), 3.0 (0.8–5.1)/1.9 (0.5–3.3), 3.2 (1.2–5.1)/2.7 (1.3–4.1), 3.2 (0.8–5.6)/2.0 (0.3–3.6), and 3.1 (1.1–5.1)/2.4 (1.1–3.8) mmHg, respectively. Conclusions:The results of this meta-analysis provide evidence that azilsartan has a more favorable efficacy profile than the other ARBs in reducing SBP and DBP.Keywords
This publication has 39 references indexed in Scilit:
- The impact of a change in hypertension management guidelines on diuretic use in Japan: trends in antihypertensive drug prescriptions from 2005 to 2011Hypertension Research, 2013
- Epidemiology of Hypertension in JapanCirculation Journal, 2013
- Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I–II essential hypertension: a randomized, double-blind clinical studyHypertension Research, 2012
- Comparative clinical- and cost-effectiveness of candesartan and losartan in the management of hypertension and heart failure: a systematic review, meta- and cost-utility analysisInternational Journal of Clinical Practice, 2011
- Comparison of the efficacy of candesartan and losartan: a meta-analysis of trials in the treatment of hypertensionJournal of Human Hypertension, 2009
- Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviewsBMJ, 2009
- Use of Indirect and Mixed Treatment Comparisons for Technology AssessmentPharmacoEconomics, 2008
- Predicting Stroke Using 4 Ambulatory Blood Pressure Monitoring-Derived Blood Pressure IndicesHypertension, 2006
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Blood Pressure Indices and Cardiovascular Disease in the Asia Pacific RegionHypertension, 2003